跳至主要内容
临床试验/IRCT2017052927520N7
IRCT2017052927520N7已完成2 期

The effects of oral nanocurcumin on expression levels of microRNA and Th17 cells development factors in ankylosing spondylitis patients

Connective Tissue Diseases Research Center0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
28 years 至 51 years(—)
性别
All

入选标准

  • Willingness to cooperate; ranging in age 28 to 51 years
  • diagnosis of ankylosing spondylitis by rheumatologist
  • patients with a BASDAI > 4 as having active disease
  • disease duration 5-8 years

排除标准

  • Use of nutritional supplements and antioxidant and immunosuppressive drugs alpha-lipoic acid a month before the study
  • pregnancy and lactation
  • history of diabetes and other chronic diseases
  • history of other autoimmune diseases
  • acceptance rate of less than 70% of supplements
  • not wanting to continue cooperation.

研究者

发起方
Connective Tissue Diseases Research Center

相似试验